Foot & Ankle Devices Market
Foot & Ankle Devices Market Size, Share & Industry Analysis, By Product (Orthopedic Implants and Devices, Bracing and Supporting Devices, Prosthetics), By Cause of Injury (Trauma, Neurological Disorders, Diabetes, Others), By End-User (Hospitals, Ambulatory Surgery Centers, Orthopedic Clinics, Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) - Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Market Overview:
The Foot & Ankle Devices Market is projected to grow at a CAGR of 6.8% from 2024 to 2031. The market value is expected to rise from USD XX billion in 2024 to USD YY billion by 2031.
North America currently dominates the market, accounting for the largest share of global revenue. Key metrics include the increasing prevalence of foot and ankle disorders, growing aging population, and advancements in orthopedic technologies.
The market is steadily expanding, owing to an increase in the frequency of sports injuries, diabetes-related foot problems, and rising demand for minimally invasive surgical procedures. Technological advancements in implant materials and designs are also fuelling market expansion.
Foot & Ankle Devices Market Dynamics:
Market Trend: Shift towards 3D-printed custom implants and orthotics
The increasing use of 3D printing technology to generate tailored implants and orthotics represents a significant advancement in the foot and ankle device sector. This technology allows for the creation of patient-specific devices that give better fit, comfort, and potentially better treatment outcomes.
Recent research has discovered that 3D-printed orthopaedic implants can lead to faster recovery times and a lower risk of complications. For example, a clinical trial published in the Journal of Foot and Ankle Surgery discovered that patients with 3D-printed complete talus replacements had considerably greater function and pain reduction than those with standard implants.
Market Driver: Increasing prevalence of diabetes and related foot complications
The rising global prevalence of diabetes and other foot problems is a primary driver of the foot and ankle device market. Diabetic foot problems, such as ulcers, infections, and, in severe cases, amputations, are creating a high demand for specialised foot devices and therapies.
According to the International Diabetes Federation, around 463 million persons had diabetes in 2019, with the total anticipated to reach 700 million by 2045. The World Health Organisation estimates that up to half of diabetics develop peripheral neuropathy, which increases the risk of foot ulcers and infections.
According to the Centres for Disease Control and Prevention, around 34.2 million people in the United States have diabetes, with foot troubles being a common and costly worry. The American Diabetes Association estimates that diabetic foot ulcers cost $9-13 billion a year, in addition to other diabetes-related costs.
The increased prevalence of diabetes and related foot problems is driving demand for a wide range of foot and ankle devices, such as specialist footwear, offloading devices, and advanced wound care solutions.
Market Restraint: High cost of technologically advanced devices
One of the most significant challenges confronting the foot and ankle device business is the high cost of complex orthopaedic implants and devices. The use of innovative materials, precision engineering, and modern technologies such as 3D printing frequently results in higher product costs, which may impede adoption, particularly in price-sensitive industries.
For example, a study published in the Journal of Foot and Ankle Surgery discovered that the average cost of total ankle replacement surgery in the United States exceeded $20,000, with the implant accounting for a significant portion of that cost. Such high costs may restrict access to these innovative therapies, particularly in areas with underdeveloped healthcare systems or limited insurance coverage.
Furthermore, the lengthy regulatory clearance processes for novel orthopaedic devices raise development costs, which are often passed on to end users. This can make it difficult for smaller businesses to enter the market and stifle industry innovation.
Segment Overview:
Orthopedic Implants and Devices segment dominates the Foot & Ankle Devices market:
The Orthopaedic Implants and Devices segment now dominates the Foot and Ankle Devices marketplace. This dominance is due in part to the expanding prevalence of degenerative joint diseases, the increased number of sports-related injuries, and advancements in implant technology.
There are numerous orthopaedic implants available for the foot and ankle, including ankle replacement implants, internal fixation devices (plates, screws, and nails), and joint fusion systems. These devices are critical for treating conditions like osteoarthritis, rheumatoid arthritis, and severe fractures.
In 2024, the global foot and ankle devices market is expected to be worth $5.2 billion, with orthopaedic implants and devices accounting for the majority of sales. This segment is likely to maintain its dominance during the forecast period, for various reasons:
-
Ageing Population: As the elderly population grows, so does the prevalence of degenerative joint diseases, increasing demand for joint replacement and fusion procedures.
-
Technological advancements include new implant materials and designs, such as 3D-printed titanium implants, which are improving surgical outcomes and patient satisfaction.
-
Minimally Invasive Procedures: The desire for minimally invasive operations is driving the development of specialist implants and instruments, hence expanding the market for these devices.
-
Sports Injuries: As people engage in more sports, the number of foot and ankle injuries rises, increasing need for orthopaedic implants and fixation devices.
Recent advances in this subject include the development of whole ankle replacement systems that improve mobility and longevity. For example, a well-known orthopaedic company recently released a new total ankle replacement system with a moveable bearing design that allows for more natural ankle mobility.
The market is also moving towards personalised implants. Companies are combining advanced imaging and 3D printing technologies to create patient-specific implants that give a better fit and perhaps improve clinical outcomes.
Regional Outlook:
North America leads the Foot & Ankle Devices market:
North America currently leads the global Foot & Ankle Devices market, accounting for the vast bulk of sales. This dominant position is attributed to a variety of factors, including sophisticated healthcare infrastructure, a high frequency of foot and ankle diseases, and significant investments in medical research and development.
The United States is the largest contributor to the North American market. The country's high healthcare expenditures, along with a large patient population suffering from foot and ankle problems, drive demand for advanced orthopaedic devices. The American Academy of Orthopaedic Surgeons estimates that over 28 million Americans have foot and ankle musculoskeletal disorders.
North America's market dominance include:
-
Chronic Disease Prevalence: Diabetes and obesity are both common risk factors for foot and ankle problems in North America. According to the Centres for Disease Control and Prevention, over 34 million Americans have diabetes, and foot problems are common.
-
advanced Healthcare System: The region's well-developed healthcare infrastructure and high adoption rate of sophisticated medical technologies contribute to market growth.
-
Strong Market Presence: North America is home to several of the world's leading foot and ankle device makers, which fuels innovation and market growth.
-
Relatively favourable reimbursement policies for orthopaedic operations in the United States help to drive market growth.
Recent trends in the North American market include the following:
-
The expanding trend of performing foot and ankle surgery in outpatient settings is driving up demand for technology developed for minimally invasive treatments.
-
North American hospitals and clinics are increasingly relying on 3D-printed tailored implants for challenging foot and ankle treatments.
-
Expanding disorders for Whole Ankle Replacement: The FDA has approved new whole ankle replacement systems for a broader range of disorders, potentially extending the patient pool for these procedures.
-
Growing Interest in Orthobiologics: Orthobiologic products are rapidly being studied and used in clinical settings for foot and ankle treatments, opening up new market opportunities.
Canada also contributes significantly to the region's market leadership, since its universal healthcare system facilitates access to advanced orthopaedic therapies. The Canadian Orthopaedic Foot and Ankle Society reports that the country's number of foot and ankle specialists is growing, indicating a stronger emphasis on this subspeciality.
Competitive Intelligence:
The Foot & Ankle Devices market is defined by the presence of both well-known companies and a growing number of innovative start-ups. To maintain their market positions and broaden their product portfolios, significant companies prioritise product innovation, strategic partnerships, and mergers and acquisitions.
Leading companies in this field include:
-
Stryker Corporation: Stryker is a prominent player in the orthopaedic device industry, offering a diverse variety of foot and ankle implants and equipment. The company's foot and ankle segment had revenues of $509 million in 2021, up 14.4% from the previous year.
-
DePuy Synthes (Johnson & Johnson) provides a wide range of foot and ankle solutions, such as plates, screws, and full ankle replacement systems. In 2021, the company's orthopaedics segment, which includes foot and ankle devices, earned $8.6 billion in revenue.
-
Zimmer Biomet Holdings, Inc. develops a variety of foot and ankle implants, including fracture repair and joint fusion. The company's foot and ankle segment has been gradually growing, with a focus on improving its minimally invasive surgery capabilities.
These companies use a range of tactics to preserve and improve their market positions:
-
Product innovation: Companies are investing heavily in R&D to develop novel implants and surgical procedures. Stryker, for example, has introduced a 3D-printed talus spacer to treat talar avascular necrosis, indicating the trend towards customised implants.
-
Mergers and Acquisitions: Strategic acquisitions are common in the market. For example, in 2021, DePuy Synthes acquired Interventional Spine, Inc. to expand its minimally invasive spine surgery portfolio, which includes foot and ankle surgeries.
-
Geographic Expansion: Many businesses are striving to expand their presence in emerging markets. Zimmer Biomet, for example, has increased its distribution network in Asia Pacific and Latin America.
-
Partnerships with Healthcare Providers: Companies collaborate with hospitals and surgeons to develop new products and enhance existing ones. These collaborations also help to conduct clinical trials and gather real-world evidence.
The market is also seeing the rise of speciality foot and ankle device companies, such as Paragon 28 and Nextremity Solutions, which are entirely focused on this area and driving innovation.
Advances in 3D printing technology, the development of smart implants with sensor technologies, and the increased emphasis on outpatient procedures needing specialised devices are all projected to alter the competitive landscape in the future.
Analyst Opinion:
The Foot & Ankle Devices market is likely to experience significant growth and innovation in the coming years, because of a combination of demographic trends, technological advancements, and altering healthcare delivery models. As an analyst, I see three major factors influencing the future of this market:
-
Customised Medicine: The rise of customised medicine is anticipated to have a substantial impact on the foot and ankle device business. Advanced imaging technologies, when combined with 3D printing capabilities, enable the creation of patient-specific implants and surgical guidance. This technique has the potential to enhance surgical outcomes, reduce complications, and boost patient satisfaction. Companies who can effectively use these technologies to create tailored solutions will gain a significant competitive advantage.
-
Minimally Invasive Techniques: There is a growing interest in minimally invasive foot and ankle procedures due to the benefits of faster recovery periods, reduced scarring, and lower infection rates. This trend is expected to drive up demand for specialised equipment and implants used in minimally invasive procedures. Companies that can develop innovative solutions in this field, such as expandable implants or improved arthroscopic equipment, are projected to grow rapidly.
-
Biologics and Regenerative Medicine: Incorporating biologics and regenerative medicine techniques into foot and ankle care represents a significant opportunity. Growth factors, stem cell therapies, and enhanced wound care solutions may promote healing and reduce the need for invasive surgeries in some cases. The regulatory landscape for these treatments is evolving, and companies who can successfully manage it while proving clear therapeutic advantages will be well positioned for future growth.
To recap, the Foot & Ankle Devices business is at an exciting stage, with great opportunities for innovation and growth. Success in this business will be decided by a company's ability to use innovative technology, adapt to changing healthcare delivery systems, and demonstrate clear value to patients, providers, and payers. Companies who can effectively manage these challenges while negotiating the complicated regulatory and reimbursement environment are likely to emerge as market leaders in this rapidly expanding field.
Major Players:
-
Stryker Corporation
-
DePuy Synthes (Johnson & Johnson)
-
Zimmer Biomet Holdings, Inc.
-
Smith & Nephew plc
-
Integra LifeSciences Holdings Corporation
-
Arthrex, Inc.
-
Wright Medical Group N.V.
-
Acumed LLC
-
Ossur hf
-
Extremity Medical, LLC
Key Developments:
-
Stryker Corporation will introduce a new 3D-printed entire ankle replacement device in October 2023, with the goal of enhancing anatomical fit and mobility for patients with end-stage ankle arthritis.
-
August 2023: The FDA approves Zimmer Biomet's AI-powered surgical planning platform for foot and ankle procedures, which seeks to improve surgical precision and patient outcomes.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope & Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking -- Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies list by Country) (Premium)
5. COMPANY PROFILES
5.1. Stryker Corporation
5.2. DePuy Synthes (Johnson & Johnson)
5.3. Zimmer Biomet Holdings, Inc.
5.4. Smith & Nephew plc
5.5. Integra LifeSciences Holdings Corporation
5.6. Arthrex, Inc.
5.7. Wright Medical Group N.V.
5.8. Acumed LLC
5.9. Ossur hf
5.10. Extremity Medical, LLC (*LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Shift towards 3D-printed custom implants and orthotics
6.1.2. Increasing adoption of minimally invasive surgical techniques
6.1.3. Growing integration of biologics and regenerative medicine approaches
6.2. Market Drivers
6.2.1. Increasing prevalence of diabetes and related foot complications
6.2.2. Rising incidence of sports injuries and road accidents
6.2.3. Growing aging population and prevalence of degenerative joint diseases
6.3. Market Restraints
6.3.1. High cost of technologically advanced devices
6.3.2. Stringent regulatory approval processes
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY PRODUCT (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
7.1. Orthopedic Implants and Devices
7.2. Bracing and Supporting Devices
7.3. Prosthetics
8. BY CAUSE OF INJURY (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
8.1. Trauma
8.2. Neurological Disorders
8.3. Diabetes
8.4. Others
9. BY END-USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
9.1. Hospitals
9.2. Ambulatory Surgery Centers
9.3. Orthopedic Clinics
9.4. Others
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. South America
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of South America
10.3. Europe
10.3.1. Germany
10.3.2. United Kingdom
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle-East
10.5.1. UAE
10.5.2. Saudi Arabia
10.5.3. Turkey
10.5.4. Rest of Middle East
10.6. Africa
10.6.1. South Africa
10.6.2. Egypt
10.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
By Product:
-
Orthopedic Implants and Devices
-
Bracing and Supporting Devices
-
Prosthetics
By Cause of Injury:
-
Trauma
-
Neurological Disorders
-
Diabetes
-
Others
By End-User:
-
Hospitals
-
Ambulatory Surgery Centers
-
Orthopedic Clinics
-
Others
By Region:
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511